◆ 会议时间：2024年3月21日至23日
◆ 会议地点：德国 慕尼黑
◆ 会议简介：
2024年第10届癌症免疫治疗大会将于2024年3月21日至23日在德国慕尼黑举行，会议由WMA GmbH与ITOC协会、慕尼黑肿瘤中心(TZM)、癌症免疫治疗协会(SITC)、德国癌症协会(DKTK)以及慕尼黑综合癌症中心(CCCM)合作举办。该会议是欧洲领先的会议，为免疫肿瘤学领域的转化研究提供一个全球性的平台-宣译。ITOC系列会议是首屈一指的癌症免疫治疗教育、科学交流会议，旨在为所有从事免疫治疗的专业人士提供一个讨论早期临床药物研发，应对转化研究所面临的独特挑战的论坛；大会议题将侧重于最新的挑战和创新，特别强调联合治疗，免疫监测和生物标志物开发(未经许可禁止复制摘录镜像本站任何内容-领域国际医学会议网)。
10th Immunotherapy of Cancer Conference (ITOC10)
Date: March 21 - 23, 2024
Venue:
Munich, Germany
The Immunotherapy of Cancer Conference (ITOC) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
摘要征文投稿：
Deadline for Abstract Submission
Sunday, December 3, 2023 at 23.59 hrs CEST
Notification of Acceptance
- Note that the first/submitting author will receive all correspondence concerning the abstract and is responsible for informing the other authors of the status of the abstract and will automatically be listed as the presenting author.
- Accepted abstracts will be presented as posters.
- Some selected abstracts will be presented orally in plenary sessions.
- Authors will be notified on acceptance and allocation per email by end of January 2024.
Presentations of abstracts
The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the ITOC10 Programme Committee.
Publication of abstracts
Accepted abstracts will be published as a supplement to the "Journal for ImmunoTherapy of Cancer".
Poster Awards
All presenters of accepted poster presentations are automatically entered in the competition of the ITOC10 Poster Awards.
The winners will be announced in the final session of the ITOC10 conference.
Topics for submission:
Abstracts can be submitted for the following topic categories:
- Basic Tumor Immunology
- New Targets and New Leads
- Exploiting B Cells and Other Cell Types
- Microbiome
- Adjuvant vs Neoadjuvant IO Treatment
- Combination Therapies
- Immuno-Monitoring
- Young Researchers Session
- Reaching New Grounds in Cellular Therapies
- Cell therapies in Hematologic Oncology
- Cell Therapies in Solid Oncology
How to apply for inclusion of your abstract in the Young Researcher Session:
All young scientists submitting for oral presentations are encouraged to apply by ticking the corresponding box in the “Topic Step” during submission.
The applicant must be first author (i.e. presenting author) of an abstract submitted for spoken presentation and should not have more than five years of postdoctoral experience (<35 years) and cannot be an established Principal Investigator (P.I.). Predoctoral students are also welcome to apply.
Please make sure to upload your short CV in the dedicated step during abstract submission. Failure to submit your CV means that your abstract cannot be considered for this session.
The best scored abstracts, which could not be selected for oral presentation will automatically compete for the ITOC10 Poster Awards.
ABSTRACT GUIDELINES - Please read the instructions carefully!
注册费：
REGISTRATION FEES (IN EUR)
all fees include 19% German VAT
Payment received by:
| Category |
Early Bird
until October 30, 2023
|
From October 31, 2023
to January 15, 202
|
From January 16, 2024
and On-Site
|
| Academia |
465,- |
565,- |
665,- |
| Junior Participant(1) |
115,- |
145,- |
190,- |
| Industry |
765,- |
865,- |
965,- |
| Foundations & Charities |
240,- |
290,- |
340,- |
| Press/Media (2) |
no fee |
no fee |
no fee |
| Welcome Reception |
no fee |
no fee |
no fee |
| Dinner |
70,- |
70,- |
70,- |
| Lunch Ticket |
20,- |
20,- |
20,- |
| Name Change |
60,- |
60,- |
60,- |
NOTE: Online pre-registration will close on March 11, 2024. After this date registration will still be possible, but only onsite at the conference venue on March 21 - 23, 2024.
(1) The “Junior Participant” registration is available for Students under 30 years of age. The “Junior Participant” registration is available for Students under 30 years of age. Please upload a copy of a student ID also indicating your age in jpeg, jpg, gif, bmp or png format within online registration.
(2) No fee, but registration is mandatory. A Press ID confirming your status must be uploaded at the moment of your registration in jpeg, jpg, gif, bmp or png format.
Payments should be made without charges to the beneficiary. Any bank charges will be collected on site.
Clearly state the participant's name(s) and the invoice number on the bank transfer.
◆ 参会对象：
临床医生、药物开发人员，肿瘤学家、企业代表，以及从事癌症免疫治疗研究的相关专业人士等等。
|
